By Karen Surabian, Thomas Stackhouse, and Rose Freel, Contributing Writers, and Rosemarie Truman, Guest Writer
The National Cancer Institute (NCI), led by the Technology Transfer Center (TTC), the Avon Foundation, and The Center for Advancing Innovation have partnered to create a “first-of-a-kind” Breast Cancer Start-up Challenge.
By Karen Surabian, Thomas Stackhouse, and Jeffrey W. Thomas, Contributing Writers
As the fall and winter seasons progress, you may be attending more scientific conferences, where you may find a number of opportunities for research collaborations.
To assist your lab in reaching its research goals through collaborations, the staff of the National Cancer Institute Technology Transfer Center (NCI TTC) can guide you through a tool box of agreements you may need for protecting your intellectual property (IP) and effectively managing your collaboration.
By Karen Surabian, Contributing Writer
Patents provide a period of exclusivity and are a way to exclude others from making, using, or selling an inventor’s novel technology. For the National Institutes of Health (NIH), patents are an incentive for an outside party to license, develop, and commercialize NIH technologies that will benefit public health, especially those that require substantial further development by an outside party, such as therapeutics and diagnostics.
By Karen Surabian, Contributing Writer
The National Cancer Institute’s Technology Transfer Center (NCI’s TTC) recently launched a redesign of its website. New graphics, color scheme, and updated features provide a user-friendly environment for finding information related to technology transfer at NCI.
You’ll be able to easily navigate the new TTC website for information about invention reporting, transferring materials and information, and collaborating/ partnering with NCI. Begin on the home page to review interesting news and events related to technology transfer at NIH.
By Karen Surabian, Thomas Stackhouse, and Jeffrey Thomas, Contributing Writers, and Bruce Crise, Guest Writer
Advancing scientific discovery is increasingly dependent on diverse and innovative partnerships, and the Cooperative Research and Development Agreement (CRADA) is an essential tool for establishing partnerships. CRADAs allow a federal laboratory to enter into collaborative research and development (R&D) projects with outside parties (commercial or nonprofit).
By Nancy Parrish, Staff Writer
The physical proximity of the SAIC-Frederick Intellectual Property (IP) Office to the NCI Technology Transfer Center (NCI-TTC) is one of the many benefits of being at the Advanced Technology Research Facility (ATRF), according to Courtney Silverthorn, Ph.D. Being in one location “has increased the effectiveness of both informal communication and formal meetings. We have already brainstormed solutions for several issues in the hallway during an informal chat,” said Silverthorn, an SAIC-Frederick IP specialist.
